SILS™ Port Laparoscopic Cholecystectomy Post Market Study

NCT ID: NCT00832767

Last Updated: 2017-12-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

202 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2012-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this trial are:

1. to assess the feasibility and safety of performing SILS™ Port Laparoscopic Cholecystectomy
2. monitor and compare the outcomes of SILS™ Port Laparoscopic Cholecystectomy versus 4PLC to objectively document the scientific merit and the perceived advantages of SILS™ Port Laparoscopic Cholecystectomy.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gallbladder Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Laparoscopic Cholecystectomy Single Incision Laparoscopic Surgery Surgical Procedures, Minimally Invasive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SILS Port

SILS™ Port Laparoscopic Cholecystectomy

Group Type ACTIVE_COMPARATOR

SILS™ port laparoscopic cholecystectomy

Intervention Type PROCEDURE

This interventional arm will have a single incision laparoscopic cholecystectomy procedure.

Four Port

Four Port Laparoscopic Cholecystectomy

Group Type ACTIVE_COMPARATOR

Four Port Laparoscopic Cholecystectomy

Intervention Type PROCEDURE

This interventional arm will have a traditional four port laparoscopic cholecystectomy procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SILS™ port laparoscopic cholecystectomy

This interventional arm will have a single incision laparoscopic cholecystectomy procedure.

Intervention Type PROCEDURE

Four Port Laparoscopic Cholecystectomy

This interventional arm will have a traditional four port laparoscopic cholecystectomy procedure.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Between 18 and 85 years old.
* Patient has a diagnosis of biliary colic with documented gallstones or polyps by imaging or Biliary dyskinesia with documented EF \< 30%.
* Body Mass Index (BMI) \< 45 kg/m2.

Exclusion Criteria

* Any female patient, who is pregnant, suspected pregnant, or nursing.
* Any patient with acute calculus or acalculous cholecystitis.
* Any patient who has had an upper midline or right sub costal incision.
* Any patient with pre-operative indication for a cholangiogram.
* Any patient with ASA \> 3 with normal liver function.
* Any patient who is undergoing Peritoneal Dialysis (PD).
* Any patient who has an unrepaired umbilical hernia or has had prior umbilical hernia repair.
Minimum Eligible Age

18 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Medtronic - MITG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeffrey Marks, MD

Role: PRINCIPAL_INVESTIGATOR

Case Medical Center University Hospitals

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Yale New Haven Medical Center

New Haven, Connecticut, United States

Site Status

Tampa General Hospital

Tampa, Florida, United States

Site Status

Northwestern Memorial Hospital

Chicago, Illinois, United States

Site Status

Tufts Medical Center

Boston, Massachusetts, United States

Site Status

North Shore - Long Island Jewish Health System

Lake Success, New York, United States

Site Status

St. Francis Hospital

Roslyn, New York, United States

Site Status

Case Medical Center

Cleveland, Ohio, United States

Site Status

UT Southwestern Medical Center

Dallas, Texas, United States

Site Status

Catholic University of Sacred Heart

Rome, , Italy

Site Status

Imperial College, England, St. Mary's Hospital

London, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Italy United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Solomon D, Shariff AH, Silasi DA, Duffy AJ, Bell RL, Roberts KE. Transvaginal cholecystectomy versus single-incision laparoscopic cholecystectomy versus four-port laparoscopic cholecystectomy: a prospective cohort study. Surg Endosc. 2012 Oct;26(10):2823-7. doi: 10.1007/s00464-012-2253-0. Epub 2012 May 2.

Reference Type DERIVED
PMID: 22549370 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AS08012

Identifier Type: -

Identifier Source: org_study_id